Literature DB >> 32489617

Population-specific effect of Wolbachia on the cost of fungal infection in spider mites.

Flore Zélé1, Mustafa Altıntaş2, Inês Santos1, Ibrahim Cakmak2, Sara Magalhães1.   

Abstract

Many studies have revealed the ability of the endosymbiotic bacterium Wolbachia to protect its arthropod hosts against diverse pathogens. However, as Wolbachia may also increase the susceptibility of its host to infection, predicting the outcome of a particular Wolbachia-host-pathogen interaction remains elusive. Yet, understanding such interactions and their eco-evolutionary consequences is crucial for disease and pest control strategies. Moreover, how natural Wolbachia infections affect artificially introduced pathogens for biocontrol has never been studied. Tetranychus urticae spider mites are herbivorous crop pests, causing severe damage on numerous economically important crops. Due to the rapid evolution of pesticide resistance, biological control strategies using entomopathogenic fungi are being developed. However, although spider mites are infected with various Wolbachia strains worldwide, whether this endosymbiont protects them from fungi is as yet unknown. Here, we compared the survival of two populations, treated with antibiotics or naturally harboring different Wolbachia strains, after exposure to the fungal biocontrol agents Metarhizium brunneum and Beauveria bassiana. To control for potential effects of the bacterial community of spider mites, we also compared the susceptibility of two populations naturally uninfected by Wolbachia, treated with antibiotics or not. In one population, Wolbachia-infected mites had a better survival than uninfected ones in absence of fungi but not in their presence, whereas in the other population Wolbachia increased the mortality induced by B. bassiana. In one naturally Wolbachia-uninfected population, the antibiotic treatment increased the susceptibility of spider mites to M. brunneum, but it had no effect in the other treatments. These results suggest that natural Wolbachia infections may not hamper and may even improve the success of biological control using entomopathogenic fungi. However, they also draw caution on the generalization of such effects, given the complexity of within-host-pathogens interaction and the potential eco-evolutionary consequences of the use of biocontrol agents for Wolbachia-host associations.
© 2020 The Authors. Ecology and Evolution published by John Wiley & Sons Ltd.

Entities:  

Keywords:  Tetranychus urticae; antibiotic treatment; bacterial community; facilitation; fungi‐induced mortality; symbiont‐mediated protection

Year:  2020        PMID: 32489617      PMCID: PMC7244807          DOI: 10.1002/ece3.6015

Source DB:  PubMed          Journal:  Ecol Evol        ISSN: 2045-7758            Impact factor:   2.912


INTRODUCTION

The maternally inherited bacterium Wolbachia is to date the best studied and probably the most common endosymbiont of arthropods. It is estimated to infect up to 52% of arthropod species (Weinert, Araujo‐Jnr, Ahmed, & Welch, 2015), a success mainly attributed to its ability to induce various types of reproductive manipulation in hosts to increase the reproductive success of infected females, thereby increasing its own transmission (Werren, Baldo, & Clark, 2008). In particular, the ability of Wolbachia to spread rapidly within and among host populations (Engelstadter & Hurst, 2009) has raised growing interests in using it in biocontrol programs (Bourtzis et al., 2014). Possible Wolbachia‐based biocontrol strategies include the use of Wolbachia as a microbial biocontrol agent, for instance to enhance productivity of natural predators and parasites such as parasitoids (e.g., Grenier et al., 1998; Stouthamer, 1993); as a potential gene‐drive vehicle for population replacement strategies through cytoplasmic drive (which provides a mechanism for the autonomous spread of desired genes into targeted populations; e.g., Dobson, 2003; Sinkins & Godfray, 2004; Turelli & Hoffmann, 1999); or for sterile insect techniques (SIT) to suppress target pest populations by repeated sweeps with infected individuals (Calvitti, Marini, Desiderio, Puggioli, & Moretti, 2015; Zhang, Lees, Xi, Gilles, & Bourtzis, 2015; Zhong & Li, 2014). Subsequently, the discovery of the ability of Wolbachia to protect its hosts against a wide array of pathogens, including viruses, protozoan parasites, fungi, or pathogenic bacteria (reviewed by Cook & McGraw, 2010) has provided new avenues for the control of vector‐borne diseases (reviewed by Iturbe‐Ormaetxe, Walker, & Neill, 2011). For instance, deliberate introductions of Wolbachia into Aedes aegypti mosquito populations are currently being undertaken successfully in several regions worldwide to control dengue virus (e.g. Hoffmann et al., 2014; Nguyen et al., 2015). However, such ability of Wolbachia to interfere with diverse host pathogens may have undesirable effects on biocontrol strategies if, for instance, natural Wolbachia infection interferes with parasitic biocontrol agents, a possibility that has never been addressed. Alternatively, natural Wolbachia infections in several host species may also increase host susceptibility to parasite infection (e.g., Graham, Grzywacz, Mushobozi, & Wilson, 2012; Hughes, Rivero, & Rasgon, 2014), raising the possibility that Wolbachia could also facilitate the action of biocontrol agents. Moreover, potentially variable effects of Wolbachia on host susceptibility to biocontrol agents may have ecological and epidemiological consequences. For instance, artificially introduced pathogens can select Wolbachia variants that increase host resistance and counter‐selection variants that increase host susceptibility to infection, thereby potentially driving the spread of defensive Wolbachia variants (e.g., Cattel, Martinez, Jiggins, Mouton, & Gibert, 2016; Jaenike, Unckless, Cockburn, Boelio, & Perlman, 2010; Kriesner & Hoffmann, 2018). Hence, assessing the effect of natural Wolbachia infection on the efficiency of different strains and/or species of parasitic biocontrol agents is a prerequisite for the development of efficient and long‐lasting control strategies (Zindel, Gottlieb, & Aebi, 2011). Spider mites of the genus Tetranychus (Acari: Tetranychidae) are ubiquitous major crop pests of c.a. 1,100 plant species belonging to more than 140 different plant families (Migeon & Dorkeld, 2006). Due to their short generation time and high fecundity, spider mites rapidly develop resistance to pesticides (Van Leeuwen, Vontas, Tsagkarakou, Dermauw, & Tirry, 2010), which has encouraged the development of alternative control strategies such as the use of essential oils or natural enemies (e.g., predators, entomopathogenic bacteria and fungi; Attia et al., 2013). Among them, entomopathogenic fungi have been successfully used in integrated pest management (IPM) programs, and commercial formulations are currently available to farmers in most parts of the world (Skinner, Parker, & Kim, 2014). In particular, fungi such as Beauveria bassiana, Metarhizium spp., Isaria spp. and Lecanicillium spp. have been identified as good candidates for efficient spider mite control (e.g., Bugeme, Maniania, Knapp, & Boga, 2008; Chandler, Davidson, & Jacobson, 2005; Maniania, Bugeme, Wekesa, Delalibera, & Knapp, 2008; Shin, Bae, Kim, Yun, & Woo, 2017), and their compatibility with other control methods, such as predatory mites (e.g., Dogan, Hazir, Yildiz, Butt, & Cakmak, 2017; Ullah & Lim, 2017; Wu, Xie, Li, Xu, & Lei, 2016) or pesticides (e.g., Klingen & Westrum, 2007; Shi, Jiang, & Feng, 2005) is widely studied. Curiously, however, the interaction between entomopathogenic fungi and bacterial endosymbionts of spider mites has, to our knowledge, never been investigated. This is at odds with the fact that, on the one hand, natural populations of spider mites often carry several maternally inherited endosymbiotic bacteria with variable prevalence, Wolbachia being the most prevalent (prevalence ranges from 0% to 100%; e.g. Gotoh, Sugasawa, Noda, & Kitashima, 2007; Zélé, Santos, et al., 2018; Zhang, Chen, Yang, Qiao, & Hong, 2016); and, on the other hand, Wolbachia has been shown to protect Drosophila melanogaster hosts against the mortality induced by B. bassiana (Panteleev et al., 2007), although no such effect has been found in D. simulans; (Fytrou, Schofield, Kraaijeveld, & Hubbard, 2006). To examine the effect of the interaction between Wolbachia and fungal infection on spider mite survival, we carried out a fully factorial experiment using two naturally Wolbachiainfected and two naturally Wolbachia‐uninfected spider mite populations belonging to two genetically differentiated forms of T. urticae (Auger, Migeon, Ueckermann, Tiedt, & Navajas Navarro, 2013) and treated or not with antibiotics. We used a strain of two generalist entomopathogenic fungi species, Beauveria bassiana and Metarhizium brunneum, as they are included in genuses that are among the most used fungi in commercial production (Vega et al., 2009), with wide geographical and host ranges (Gurlek, Sevim, Sezgin, & Sevim, 2018; Meyling & Eilenberg, 2007; Roberts & Leger, 2004). The specific aims of this work were to determine: (a) whether infection with a natural Wolbachia strain protects spider mites against fungus‐induced mortality, (b) whether this effect varies with different Wolbachia strains and/or the presence of other bacteria in spider mites, and (c) whether this effect depends on the fungus strain. We then discuss possible mechanisms leading to our results, the importance of considering the whole bacterial community of arthropods when assessing the effect of Wolbachia, as well as the potential eco‐evolutionary consequences of the presence of Wolbachia for the success of spider mite control strategies using entomopathogenic fungi.

MATERIALS AND METHODS

Spider mite populations and rearing

Four populations were used in this study, two belonging to the “red” form (AlRo and AMP), and two belonging to the “green” form (DEF and TOM) of Tetranychus urticae (Auger et al., 2013). These populations have been collected in the Iberian Peninsula from 2010 to 2017, on different plant species. Upon collection from the field, the populations AMP and TOM were found to be naturally and fully infected by two different strains of Wolbachia. The population AMP is infected by the Wolbachia strain ST481 (isolate “Turt_B_wUrtAmp,” id: 1858 in the PubMLST Wolbachia database; http:// http://www.pubmlst.org/wolbachia/), which is very similar to strain ST219 belonging to supergroup B and found in China by Zhang, Ding, Zhang, and Hong (2013); and the population TOM is infected by the Wolbachia strain ST280 (isolate “Turt_B_wUrtTom,” id: 1857), which has also been previously found in China by Zhang, Ding, et al. (2013). These strains are very closely related, having 1 SNP difference on the sequences of both the fbpA and coxA genes in the multilocus sequence typing (MLST) system developed by Baldo et al. (2006) for Wolbachia. The two other populations, AlRo and DEF, were naturally uninfected by Wolbachia and none of the populations used in this study carried other maternally inherited bacterial endosymbionts (i.e., Cardinium, Rickettsia, Spiroplasma, and Arsenophonus) at the time of the experiment, as confirmed by PCR using the methods described in Zélé, Santos, et al. (2018). All the information concerning these populations is summarized in Table 1. After collection, these populations were reared in the laboratory under standard conditions (24 ± 2°C, 60% RH, 16/8h L/D) at high numbers (c.a. 500–1000 females per population) in insect‐proof cages containing bean plants (Phaseolus vulgaris, cv. Contender seedlings obtained from Germisem, Oliveira do Hospital, Portugal).
Table 1

Populations of spider mites used in the experiment. Mites were collected in Portugal (P) and Spain (S) and were naturally infected, or not, by Wolbachia. The absence of other maternally inherited endosymbionts (Cardinium, Rickettsia, Spiroplasma, Arsenophonus) in these populations was confirmed by PCR before the onset of the experiment (using methods described in Zélé, Santos, et al., 2018; Zélé, Weill, et al., 2018)

NameDateHost plantLocationCoordinates Wolbachia infectionReference
AlRo09/11/2013 Rosa spp. Almería (S)36.855725, −2.320374no(Zélé, Santos, et al., 2018)
DEF26/04/2017 Solanum lycopersicum Alvalade, Lisbon (P)38.75515, −9.14685no
AMP18/11/2013 Datura stramonium Aldeia da Mata Pequena (P)38.534363, −9.191163yes (ST481a)(Zélé, Santos, et al., 2018)
TOM‐‐/05/2010 Solanum lycopersicum Carregado (P)39.078962,−8.993656yes (ST280b)(Clemente, Rodrigues, Ponce, Varela, & Magalhães, 2016)

Isolate “Turt_B_wUrtTom”—id: 1857, Wolbachia strain ST280. This strain has been first identified as wTurt_2 from three different populations of T. urticae in China (Zhang, Zhang, et al., 2013).

Isolate “Turt_B_wUrtAmp”—id: 1858, Wolbachia strain ST481. This is a new strain, very similar to the strain ST219 (they differ by 1 SNP on the fbpA gene: allele 444 instead of allele 4) that was found in China by Zhang, Ding, et al. (2013).

Populations of spider mites used in the experiment. Mites were collected in Portugal (P) and Spain (S) and were naturally infected, or not, by Wolbachia. The absence of other maternally inherited endosymbionts (Cardinium, Rickettsia, Spiroplasma, Arsenophonus) in these populations was confirmed by PCR before the onset of the experiment (using methods described in Zélé, Santos, et al., 2018; Zélé, Weill, et al., 2018) Isolate “Turt_B_wUrtTom”—id: 1857, Wolbachia strain ST280. This strain has been first identified as wTurt_2 from three different populations of T. urticae in China (Zhang, Zhang, et al., 2013). Isolate “Turt_B_wUrtAmp”—id: 1858, Wolbachia strain ST481. This is a new strain, very similar to the strain ST219 (they differ by 1 SNP on the fbpA gene: allele 444 instead of allele 4) that was found in China by Zhang, Ding, et al. (2013).

Antibiotic treatments

Roughly 2 months (ca. 4 generations) before the onset of the experiment, a rifampicin solution (0.05%, w/v) was used to treat mites (n = 70 adult females initially) from each population for one generation (see Gotoh et al., 2005). This allowed us to obtain Wolbachia‐uninfected AMP and TOM populations as well as controls for the antibiotic treatment for the naturally uninfected populations AlRo and DEF. During the treatment, mites were maintained in Petri dishes containing bean leaf fragments placed on cotton with the antibiotic solution. After one generation, 100 adult‐mated daughters from each treated population were transferred in insect‐proof cages containing bean plants, in the same laboratory conditions as the untreated populations, and these new populations were allowed to grow for 3 successive generations in the absence of antibiotics to avoid potential side effects of the treatment (e.g., Ballard & Melvin, 2007). One generation before the onset of the experiment, pools of 100 females were taken from each treated population and checked by PCR to confirm that they were uninfected by Wolbachia (detailed procedure in Zélé, Weill, & Magalhães, 2018). This method allows detecting Wolbachia infection even at low frequencies (up to 1/100; Zélé, Weill, et al., 2018).

Entomopathogenic fungi strains and preparation of inoculum

We used the strains V275 (= Met52, F52, BIPESCO 5) of Metarhizium brunneum and UPH‐1103 of Beauveria bassiana (obtained from Swansea University; UK, and from Siedlce University; Poland, respectively), as they were previously shown to have the potential to suppress T. urticae populations (Dogan et al., 2017). The procedures used for fungal growth, inoculum preparation, and spider mite infection are similar to that described in Dogan et al. (2017). Briefly, the two fungi were grown on Sabouraud Dextrose Agar (SDA) medium at 25°C for 2 weeks. Conidia were harvested from sporulating cultures with the aid of a spatula, washed with sterile distilled water and filtered through 4 layers of gauze (pore size: 20 µm) to remove any hyphae.

Spider mite infection and survival

The experiment was conducted in a growth chamber under standard conditions (25 ± 2°C, 80% RH, 16/8 hr L/D). Roughly 2 weeks prior to the experiment, 100 females were collected from each mass culture and allowed to lay eggs during 4 days on detached bean leaves placed on water‐soaked cotton. One day prior to the onset of the experiment, 20 young adult mated females (hence with similar age) were randomly collected from these cohorts and placed on a 9 cm2 bean leaf disc on wet cotton with the abaxial surface facing upwards. On the first day of the experiment, the surface of the leaf discs was sprayed using a hand sprayer with 2.5 ml of a spore suspension of M. brunneum or B. bassiana in 0.03% (v/v) aqueous Tween 20 at 1 × 107 conidia/ml (which is the most commonly used concentration in laboratory studies; Dogan et al., 2017), or, as a control, with 0.03% aqueous Tween 20 only. Subsequently, female survival was monitored every 24 hr during 10 days by counting both dead and alive individuals. A total of twelve replicates per treatment (fungi infection and antibiotic treatment) and per population were performed within 2 experimental blocks of one day difference (6 replicates of each treatment per block).

Statistical analysis

Analyses were carried out using the R statistical package (version 3.5.3). The general procedure for building the statistical models was as follows. Spider‐mite populations (AlRo, AMP, DEF, and TOM), antibiotic treatment (treated with rifampicin or not), and infection treatment (sprayed with BB: Beauveria bassiana, with MB: Metarhizium brunneum, or with Tween 20 only as control) were fitted in as fixed explanatory variables, whereas discs nested within population and block were fitted as random explanatory variables. When a significant three‐way interaction between the three fixed variables was found, each population was analyzed separately with the same model structure, except that the variable population was removed from the model. Survival data were analyzed using Cox proportional hazards mixed‐effect models (coxme, kinship package). Hazard ratios (HR) were obtained from these models as an estimate of the difference between the rates of dying (Crawley, 2007) between the untreated controls and the BB or MB treatments for each population. Because the timing of infection is an important parameter for the fitness of parasites, an additional early measurement of survival, the proportion of dead mites at 3 days postinfection (dpi), was obtained from Kaplan–Maier estimates of the survival distribution for each disc. This timing was chosen as it is close to the median survival upon infection in most of the populations tested, and hence corresponds to a threshold time‐point to unravel differences between treatments. The numbers of dead and alive mites at 3 dpi were computed using the function cbind and analyzed with a mixed model glmmadmb procedure (glmmADMB package) with a negative binomial error distribution to correct for overdispersed errors (family “nbinom1” with a ص variance). Maximal models, including all higher‐order interactions, were simplified by sequentially eliminating non‐significant terms and interactions to establish a minimal model (Crawley, 2007). The significance of the explanatory variables was established using chi‐squared tests (Bolker, 2008). The significant chi‐squared values given in the text are for the minimal model, whereas nonsignificant values correspond to those obtained before deletion of the variable from the minimal model. To explore significant interactions between infection and antibiotic treatment effects on female survival and mortality at 3 dpi, the two factors were concatenated to fit a single fixed factor containing all treatment levels in the models (i.e., 6 levels for infection by antibiotic treatment effects within each population). Multiple comparisons between levels were then performed from these models using General Linear Hypotheses (glht, package multicomp) with Bonferroni corrections, which uses classical Chisq (Wald test) for testing the global hypothesis H.

RESULTS

Overall, depending on whether they were naturally infected or uninfected by Wolbachia, the survival of females from different populations was not evenly affected by fungal infection and by rifampicin treatment (fungal infection x rifampicin treatment x population interaction: X = 36.16, p < .0001 and X = 18.33, p = .005 on the overall survival of spider mites and on their mortality at 3 days postinfection, respectively). Thus, to understand this three‐way interaction, we looked at the effect of fungal infection and of the antibiotic treatment in each population separately.

Effect of fungal infection and of antibiotic treatment in the naturally Wolbachia‐uninfected population AlRo

In the population AlRo, the two fungal strains affected differently the survival of spider mites depending on whether they were treated with antibiotics or not (fungal infection x rifampicin treatment interaction: X = 9.53, p = .009; Figure 1a). Indeed, M. brunneum (MB) induced a stronger mortality in rifampicin‐treated mites than in untreated mites (z = 2.80, p = .05), while B. bassiana (BB) induced the same mortality in both rifampicin‐treated and untreated mites (z = −1.20, p = 1.00 Figure 1b; Table 2a). In both cases, however, M. brunneum induced a stronger mortality than B. bassiana (MB vs. BB: z = 6.72, p < .0001 and z = 2.81, p = .05 in rifampicin‐treated and untreated mites, respectively). At 3 days postinfection (dpi), however, no significant interaction between fungal infection and rifampicin treatment (X = 1.78, p = .41; Figure 1c) and no effect of the antibiotics treatment alone (X = 0.90, p = .34) on female mortality were found. Both fungi strains severely increased the mortality of both rifampicin‐treated and rifampicin‐untreated mites at this early age of infection (X = 135.68, p < .00014; see Table 3a for all multiple comparisons).
Figure 1

Survival curves (proportion surviving ± s.e.) (a,d,g,j), relative mortality (estimated log hazard ratio ± s.e.) (b,e,h,k), and average survival (± s.e.) at 3 dpi (c,f,i,l) of spider mites from the naturally Wolbachia‐uninfected populations AlRo (a,b,c) and DEF (d,e,f), and the naturally Wolbachia‐infected populations AMP (g,h,i) and TOM (j,k,l). Adult females were treated (dashed lines, dashed bars, and empty circles) or not (solid lines, filled bars, and circles) with rifampicin, and sprayed with B. bassiana (orange), M. brunneum (red), or Tween 20 only as control (blue)

Table 2

Results of multiple comparisons (with Bonferroni correction) between hazard ratios obtained for the naturally Wolbachia‐uninfected populations (a) AlRo, and (b) DEF, and for the naturally Wolbachia‐infected populations (c) AMP, and (d) TOM sprayed or not with fungi (BB: Beauveria bassiana; MB: Metarhizium brunneum; Control: Tween 20 only) and treated or not with antibiotics (rif: rifampicin‐treated; nt: untreated)

(a) Naturally Wolbachia‐uninfected population AlRo
Treatments comparedEstimateStd. Errorz value p‐value
Control_rifversusControl_nt0.2720.1461.869.554
BB_rifversusBB_nt−0.1100.092−1.2001.000
MB_ rifversusMB_nt0.2590.0932.802.046a
BB_ ntversusControl_nt2.5780.14417.931<2e‐16a
MB_ntversusControl_nt2.8400.14419.718<2e‐16a
MB_ ntversusBB_nt0.2620.0932.810.045a
BB_ rifversusControl_rif2.1950.13416.345<2e‐16a
MB_rifversusControl_rif2.8270.13920.410<2e‐16a
MB_ rifversusBB_rif0.6320.0946.7181.66E‐10a

* p‐value < .05,

** p‐value < .01,

*** p‐value < .001.

Table 3

Results of multiple comparisons (with Bonferroni correction) between mortality at 3 dpi of the naturally Wolbachia‐uninfected populations (a) AlRo, and (b) DEF, and for the naturally Wolbachia‐infected populations (c) AMP, and (d) TOM sprayed or not with fungi (BB: Beauveria bassiana; MB: Metarhizium brunneum; Control: Tween 20 only) and treated or not with antibiotics (rif: rifampicin‐treated; nt: untreated)

(a) Naturally Wolbachia‐uninfected population AlRo
Treatments comparedEstimateStd. Errorz value p‐value
Control_rifversusControl_nt0.3270.2361.3871.000
BB_rifversusBB_nt−0.0120.247−0.0491.000
MB_ rifversusMB_nt0.0850.1750.4891.000
BB_ ntversusControl_nt1.6840.1968.607<2e−16a
MB_ntversusControl_nt1.8180.1949.386<2e−16a
MB_ ntversusBB_nt0.1340.2320.5791.000
BB_ rifversusControl_rif1.3450.2914.6143.55E−05a
MB_rifversusControl_rif1.5760.2765.7021.06E−07a
MB_ rifversusBB_rif0.2320.2021.1451.000

* p‐value < .05,

** p‐value < .01,

*** p‐value < .001.

Survival curves (proportion surviving ± s.e.) (a,d,g,j), relative mortality (estimated log hazard ratio ± s.e.) (b,e,h,k), and average survival (± s.e.) at 3 dpi (c,f,i,l) of spider mites from the naturally Wolbachia‐uninfected populations AlRo (a,b,c) and DEF (d,e,f), and the naturally Wolbachiainfected populations AMP (g,h,i) and TOM (j,k,l). Adult females were treated (dashed lines, dashed bars, and empty circles) or not (solid lines, filled bars, and circles) with rifampicin, and sprayed with B. bassiana (orange), M. brunneum (red), or Tween 20 only as control (blue) Results of multiple comparisons (with Bonferroni correction) between hazard ratios obtained for the naturally Wolbachia‐uninfected populations (a) AlRo, and (b) DEF, and for the naturally Wolbachiainfected populations (c) AMP, and (d) TOM sprayed or not with fungi (BB: Beauveria bassiana; MB: Metarhizium brunneum; Control: Tween 20 only) and treated or not with antibiotics (rif: rifampicin‐treated; nt: untreated) * p‐value < .05, ** p‐value < .01, *** p‐value < .001. Results of multiple comparisons (with Bonferroni correction) between mortality at 3 dpi of the naturally Wolbachia‐uninfected populations (a) AlRo, and (b) DEF, and for the naturally Wolbachiainfected populations (c) AMP, and (d) TOM sprayed or not with fungi (BB: Beauveria bassiana; MB: Metarhizium brunneum; Control: Tween 20 only) and treated or not with antibiotics (rif: rifampicin‐treated; nt: untreated) * p‐value < .05, ** p‐value < .01, *** p‐value < .001.

Effect of fungal infection and of antibiotic treatment in the naturally Wolbachia‐uninfected population DEF

In the population DEF, we did not find a significant interaction between fungal infection and rifampicin treatment (X = 0.65, p = .72; Figure 1d), neither a significant effect of rifampicin treatment (X = 0.003, p = .96), but only a significant effect of fungal infection (X = 879.17, p < .0001). Indeed, both fungi induced the same mortality in rifampicin‐treated and in rifampicin‐untreated mites, with an overall stronger effect of M. brunneum than of B. bassiana (Figure 1e; Table 2b for all multiple comparisons). Similarly, at 3 dpi, no significant interaction between fungal infection and rifampicin treatment (X = 0.40, p = .82; Figure 1f), neither a significant effect of rifampicin treatment (X = 0.14, p = .71) was found. As for the population AlRo, only fungal infection affected the spider‐mite survival (X = 64.89, p < .0001; Table 3b for all multiple comparisons).

Effect of fungal infection and of antibiotic treatment in the naturally Wolbachia‐infected population AMP

In the population AMP, we found a significant interaction between infection and rifampicin treatment (X = 26.61, p < .0001; Figure 1g). This interaction was due to a lower survival of Wolbachiainfected controls compared with rifampicin‐treated controls (z = −4.92, p < .0001) only, as Wolbachiainfected and rifampicin‐treated mites had the same overall survival upon infection with each fungal strain (for B. bassiana: z = −0.26, p = 1.00; for M. brunneum: z = 1.88, p = .55; Figure 1h and Table 2c). However, accounting for this difference between Wolbachiainfected and rifampicin‐treated controls reveals that, relative to their respective control, both fungi induced higher mortality in rifampicin‐treated mites (HR = 17.87 and HR = 33.39, for BB and MB, respectively) than in Wolbachiainfected ones (HR = 8.60 and HR = 13.21, respectively). A significant interaction between infection and rifampicin treatment was also found at 3 dpi (X = 6.5, p = .04; Figure 1i). However, this interaction was relatively weak at this time‐point and could not be explained by multiple comparisons between factor levels (i.e., no differences were found between Wolbachiainfected and rifampicin‐treated mites when sprayed with Tween 20 only, B. bassiana, or M. brunneum; Table 3c for all multiple comparisons).

Effect of fungal infection and of antibiotic treatment in the naturally Wolbachia‐infected population TOM

In the population TOM, we also found a significant interaction between infection and rifampicin treatment (X = 26.00, p < .0001; Figure 1j). In this population, the effect of B. bassiana was weaker in rifampicin‐treated (HR = 3.49) than Wolbachiainfected mites (HR = 5.53; z = −5.54, p < .0001; Figure 1k and Table 2d), while M. brunneum had the same effect in both rifampicin‐treated and nontreated mites (HR = 6.75 and HR = 5.56, respectively; z = 1.58, p = 1.00). Moreover, whereas both fungi had the same effect on nontreated mites (MB vs. BB: z = 0.05, p = 1.00), B. bassiana did not decrease the survival of rifampicin‐treated mites as much as M. brunneum (MB vs. BB: z = −6.88, p < .0001). This effect was even stronger at 3 dpi (fungal infection x rifampicin interaction: X = 15.44, p < .001). At this time‐point, B. bassiana induced the same mortality as M. brunneum in Wolbachiainfected mites (BB vs. Control: z = 6.24, p < .0001), but did not affect significantly the survival of rifampicin‐treated mites (BB vs. Control: z = 0.75, p = 1.00; Figure 1l and Table 3d).

DISCUSSION

In this study, we found variable effects of infection by B. bassiana and M. brunneum following antibiotic treatment, depending on the spider mite population and on whether spider mites were naturally infected by Wolbachia or not. Indeed, the mortality induced by both fungi did not differ between Wolbachiainfected and rifampicin‐treated mites in the population AMP, despite Wolbachia infection being costly in absence of fungal infection. Similarly, the mortality induced by M. brunneum was not affected by Wolbachia infection in the population TOM, but the mortality induced by B. bassiana increased in presence of Wolbachia. These results suggest that Wolbachia may buffer, or conversely increase, the effect of fungal infection depending on the fungi strains, the Wolbachia strain and/or the host genetic background. Moreover, in absence of natural Wolbachia infection, we found a relatively small effect of the antibiotic treatment on mite susceptibility to infection: The antibiotic treatment had no effect on the outcome of infection by fungi, with the exception of a higher mortality in rifampicin‐treated mites from the population AlRo when infected with M. brunneum. This effect, although significant, is of relatively low amplitude and in the opposite direction than that observed in the Wolbachiainfected population TOM following B. bassiana infection. This suggests that the effect of Wolbachia in the population TOM may not be explained by an alteration of the whole bacterial community in mites following antibiotic treatment. However, because the effect of fungal infection and antibiotic treatment vary between populations independently of the presence of Wolbachia, we draw caution on the generalization of such results. In different arthropod host species, Wolbachia may either protect (e.g., Braquart‐Varnier et al., 2015; Hughes, Koga, Xue, Fukatsu, & Rasgon, 2011; Kambris, Cook, Phuc, & Sinkins, 2009; Moreira et al., 2009; Panteleev et al., 2007; Teixeira, Ferreira, & Ashburner, 2008), have no effect (e.g., Tortosa, Courtiol, Moutailler, Failloux, & Weill, 2008; Wong, Hedges, Brownlie, & Johnson, 2011; Zouache, Michelland, Failloux, Grundmann, & Mavingui, 2012), or even increase the susceptibility (e.g., Graham et al., 2012; Hughes et al., 2014) of its arthropod hosts to infection depending on the pathogens tested, the Wolbachia strain (e.g., Chrostek et al., 2013; Martinez et al., 2017; Osborne, Leong, O'Neill, & Johnson, 2009), but also the host genetic background (although to a lesser extent; e.g. Martinez et al., 2017). In several of these studies the effect of Wolbachia on host susceptibility to pathogens has been assessed following artificial Wolbachia infection (e.g., Joubert et al., 2016; Moreira et al., 2009; Walker et al., 2011), which prevents a direct alteration of the host bacterial community but may not accurately reflect the effect of natural Wolbachia infections. Indeed, novel Wolbachia‐host associations are often costly for hosts (e.g., McGraw, Merritt, Droller, & O'Neill, 2002), mainly due to the activation of the host immune system, which in turn prevents subsequent infections by other pathogens (reviewed by Zug & Hammerstein, 2015). Conversely, the effect of natural Wolbachia infections on host susceptibility to pathogens is usually assessed by using antibiotic treatments. However, antibiotics do not affect Wolbachia only, but also the entire bacterial community in hosts (e.g., Lehman, Lundgren, & Petzke, 2009; Zouache, Voronin, Tran‐Van, & Mavingui, 2009), which raises the necessity to assess the effect of the antibiotic treatment per se. In T. truncatus spider mites, Zhu et al. (2018) showed that antibiotic treatment affects the composition of the bacterial community even after more than 20 generations without antibiotics. In particular, bacteria from different families increased in proportion in tetracycline‐treated mites in absence of the Anaplasmataceae (which includes Wolbachia). Hence, in our study, the lower mortality observed for antibiotic‐treated mites following infection by B. bassiana in the naturally Wolbachiainfected population TOM cannot be unambiguously attributed to Wolbachia only. This result could be explained, for instance, by Wolbachia outcompeting bacteria that contribute to the host homeostasis and immunity (reviewed by Shapira, 2016; Vavre & Kremer, 2014; Weiss & Aksoy, 2011), thereby increasing the success of B. bassiana infection (i.e., indirect facilitation; Zélé, Magalhães, Kéfi, & Duncan, 2018). In contrast, in the Wolbachia‐uninfected population AlRo, antibiotic‐treated mites have a higher mortality than untreated mites when infected with M. brunneum. One possible explanation is that, in the absence of natural Wolbachia infection, the antibiotic treatment affected differently the bacterial community, potentially eliminating bacteria that interfere with M. brunneum. The apparent facilitation of B. bassiana by Wolbachia in the TOM population may also be due to Wolbachia interacting directly with the host immune system. Indeed, Wolbachia can downregulate autophagy‐associated genes in naturally infected hosts, possibly as an immune evasion strategy (Chevalier et al., 2012; Kremer et al., 2009). Under such scenario, the elimination of Wolbachia with antibiotics may result in overall higher autophagic processes in the host, to which B. bassiana could be susceptible. Moreover, in diverse native hosts, including T. urticae, Wolbachia also plays a role in redox homeostasis (e.g., Zhang, Ding, Rong, & Hong, 2015; Zug & Hammerstein, 2015). The elimination of Wolbachia with antibiotics in coevolved T. urticae hosts may thus potentially lead to a disruption of redox homeostasis and higher production of reactive oxygen species (ROS), which are involved in host immunity (e.g., encapsulation, melanisation; reviewed by Zug & Hammerstein, 2015), thereby increasing host resistance to infection. However, all these different scenarios would only explain our results if such mechanisms affect differently the two fungal strains and are specific to the Wolbachia strain and/or the host population. As stated above, the host genetic background also plays a major role in determining host susceptibility to infection. First, not all populations (independently of their status of infection by Wolbachia) are equally affected by the infection by the two fungi (e.g., the mortality induced by both fungi is stronger in the population DEF than in the population TOM). Indeed, we have previously shown both inter‐ and intraspecific variability in spider mite susceptibility to infection by the same two fungi (Zélé et al. in press). Second, host susceptibility to infection may also result from Genotype x Genotype interactions with their endosymbionts (e.g., Martinez et al., 2017). Here, the different effects of Wolbachia observed in the populations TOM and AMP cannot be unambiguously attributed to the Wolbachia strain only, but likely result from their interaction with the host genetic background. Hence, although further investigations on the respective role of the Wolbachia strain and of the host genome in the susceptibility to different fungal strains (e.g., by using several spider mite populations infected by the same and different Wolbachia strains and by different fungal strains belonging to different species), as well as on the composition of the bacterial communities in each of the population tested would be necessary to shed light on the mechanisms involved, these results show that the outcome of infection strongly depends on complex interactions between multiple microorganisms and their host. Irrespective of the underlying mechanisms, the variable effects of Wolbachia on spider mite susceptibility observed here raise important questions about the potential consequences of the use of biocontrol agents for both the ecology and epidemiology of naturally occurring Wolbachia infection in arthropod pests. Indeed, the artificial introduction of pathogens for biocontrol may counter‐select susceptible Wolbachia‐host combinations and potentially select for defensive Wolbachia variants, leading to their spread across host populations (e.g., Cattel et al., 2016; Jaenike et al., 2010; Kriesner & Hoffmann, 2018). A better understanding of the variability in the outcome of Wolbachia‐host–pathogens interactions, as well as its consequences for the ecology and evolution of all players of such interaction, is thus a challenge with both fundamental and applied interests, and future work should go in that direction. In conclusion, our results show variable effects of Wolbachia on spider mite susceptibility to fungi‐induced mortality using two generalist fungi, B. bassiana and M. brunneum. To our knowledge, this is the first study investigating the interaction between natural Wolbachia infections and widely used biocontrol agents. As Wolbachia was found to have either no effect or to increase spider mite susceptibility to fungal infection, these results suggest that it may improve the success of biological control using entomopathogenic fungi. However, these results also highlight the complexity of within‐host–pathogens interaction and caution against the generalization of such effects as (a) the outcome of these interactions may vary depending on the fungal strain, the Wolbachia strain, and the host genetic background, and (b) these interactions may evolve at a rapid pace with potentially important consequences for the ecology and epidemiology of Wolbachia infection in arthropod pests. Finally, our findings also point to the importance of considering the whole bacterial community of arthropods when assessing the effect of Wolbachia in a particular system.

CONFLICT OF INTEREST

None declared.

AUTHORS’ CONTRIBUTIONS

FZ and SM conceived and designed the experiment; IS was involved in the maintenance of spider mite populations and plants; MA acquired the data; FZ performed statistical analyses; FZ and SM wrote the manuscript, with input from all authors; IC and SM funded the study. All authors have read and approved the final version of the manuscript.
  60 in total

Review 1.  Metarhizium spp., cosmopolitan insect-pathogenic fungi: mycological aspects.

Authors:  Donald W Roberts; Raymond J St Leger
Journal:  Adv Appl Microbiol       Date:  2004       Impact factor: 5.086

Review 2.  Wolbachia: master manipulators of invertebrate biology.

Authors:  John H Werren; Laura Baldo; Michael E Clark
Journal:  Nat Rev Microbiol       Date:  2008-10       Impact factor: 60.633

Review 3.  Gut Microbiotas and Host Evolution: Scaling Up Symbiosis.

Authors:  Michael Shapira
Journal:  Trends Ecol Evol       Date:  2016-03-30       Impact factor: 17.712

4.  Tetracycline treatment influences mitochondrial metabolism and mtDNA density two generations after treatment in Drosophila.

Authors:  J W O Ballard; R G Melvin
Journal:  Insect Mol Biol       Date:  2007-12       Impact factor: 3.585

5.  Symbiont strain is the main determinant of variation in Wolbachia-mediated protection against viruses across Drosophila species.

Authors:  Julien Martinez; Ignacio Tolosana; Suzan Ok; Sophie Smith; Kiana Snoeck; Jonathan P Day; Francis M Jiggins
Journal:  Mol Ecol       Date:  2017-05-30       Impact factor: 6.185

6.  Wolbachia infections are virulent and inhibit the human malaria parasite Plasmodium falciparum in Anopheles gambiae.

Authors:  Grant L Hughes; Ryuichi Koga; Ping Xue; Takema Fukatsu; Jason L Rasgon
Journal:  PLoS Pathog       Date:  2011-05-19       Impact factor: 6.823

7.  Wolbachia-mediated antibacterial protection and immune gene regulation in Drosophila.

Authors:  Zhee Sheen Wong; Lauren M Hedges; Jeremy C Brownlie; Karyn N Johnson
Journal:  PLoS One       Date:  2011-09-29       Impact factor: 3.240

8.  Wolbachia can enhance Plasmodium infection in mosquitoes: implications for malaria control?

Authors:  Grant L Hughes; Ana Rivero; Jason L Rasgon
Journal:  PLoS Pathog       Date:  2014-09-04       Impact factor: 6.823

9.  Variation in antiviral protection mediated by different Wolbachia strains in Drosophila simulans.

Authors:  Sheree E Osborne; Yi San Leong; Scott L O'Neill; Karyn N Johnson
Journal:  PLoS Pathog       Date:  2009-11-13       Impact factor: 6.823

Review 10.  Ecology and evolution of facilitation among symbionts.

Authors:  Flore Zélé; Sara Magalhães; Sonia Kéfi; Alison B Duncan
Journal:  Nat Commun       Date:  2018-11-19       Impact factor: 14.919

View more
  1 in total

1.  Impacts of fungal entomopathogens on survival and immune responses of Aedes albopictus and Culex pipiens mosquitoes in the context of native Wolbachia infections.

Authors:  Jose L Ramirez; Molly K Schumacher; Geoff Ower; Debra E Palmquist; Steven A Juliano
Journal:  PLoS Negl Trop Dis       Date:  2021-11-29
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.